See the attachment below, need it by 12pm Central Standard T…

Title: The Role of Non-Coding RNAs in Cancer Development and Progression


Cancer is a complex disease characterized by the uncontrolled growth and spread of abnormal cells. It is a leading cause of mortality worldwide, posing a significant burden on healthcare systems. While extensive research has been conducted to understand the molecular mechanisms driving cancer, it has become increasingly evident that coding genes alone do not fully explain the intricacies and heterogeneity of this disease.

Non-coding RNAs (ncRNAs) have emerged as critical players in cancer development and progression. NcRNAs are a diverse group of RNA molecules that are not translated into proteins. They can be classified into two main categories based on their size: small ncRNAs, including microRNAs (miRNAs), and long ncRNAs (lncRNAs). These molecules have been shown to regulate gene expression at various levels and are involved in multiple biological processes. In recent years, the dysregulation of ncRNAs has been implicated in numerous cancer types, highlighting their potential as promising therapeutic targets.

The Role of MicroRNAs in Cancer:

MicroRNAs (miRNAs) are small ncRNAs, approximately 22 nucleotides in length, that play crucial roles in post-transcriptional gene regulation. They achieve this by base-pairing with messenger RNAs (mRNAs), leading to mRNA degradation or translational repression. Dysregulation of miRNAs has been observed in various types of cancer, suggesting their contribution to tumor initiation, progression, and metastasis.

MiRNAs can act as oncogenes or tumor suppressors, depending on the specific targets they regulate. For example, miR-21 is frequently upregulated in many cancer types and promotes cell proliferation, migration, and invasion by targeting tumor suppressor genes. Conversely, miR-34a acts as a tumor suppressor by inhibiting the expression of genes involved in cell cycle progression and apoptosis. Studies have shown that the expression levels of specific miRNAs can serve as diagnostic or prognostic markers for particular cancer types.

The Role of Long Non-Coding RNAs in Cancer:

Long non-coding RNAs (lncRNAs) are a diverse class of ncRNAs that are longer than 200 nucleotides and lack protein-coding potential. They have emerged as key regulators of gene expression, participating in diverse cellular processes such as chromatin remodeling, transcriptional regulation, and post-transcriptional modulation. Dysregulation of lncRNAs has been implicated in various cancers, often contributing to tumor growth, metastasis, and therapy resistance.

Several lncRNAs have been identified as oncogenes or tumor suppressors in different cancer types. For instance, HOTAIR (HOX transcript antisense RNA) is upregulated in many cancers, including breast and colorectal cancer, and promotes metastasis by epigenetically silencing metastasis suppressor genes. MALAT1 (metastasis-associated lung adenocarcinoma transcript 1) is another lncRNA that is frequently upregulated in multiple cancer types and is associated with poor prognosis and metastasis. Similarly, NEAT1 (nuclear paraspeckle assembly transcript 1) has been shown to promote cancer cell proliferation and invasion.

Mechanisms of Non-Coding RNA Dysregulation in Cancer:

The dysregulation of ncRNAs in cancer can occur through various mechanisms. One common mechanism involves alterations in the expression levels of specific ncRNAs. For example, genetic amplification or deletion events can lead to increased or decreased expression of oncogenic or tumor suppressive ncRNAs, respectively. Additionally, aberrant expression of transcription factors or epigenetic modifiers can directly influence ncRNA expression profiles in cancer cells.

Another mechanism of ncRNA dysregulation involves alterations in the processing or maturation of ncRNAs. Processing defects can lead to the accumulation of aberrant forms of ncRNAs or impair their functionality. For example, mutations in the miRNA processing machinery have been linked to the dysregulation of specific miRNAs in cancer.


Non-coding RNAs have emerged as critical regulators of gene expression in cancer. The dysregulation of miRNAs and lncRNAs has been shown to play a significant role in cancer initiation, progression, and metastasis. Understanding the precise functions and mechanisms of ncRNAs in cancer will pave the way for the development of novel therapeutic strategies targeting these molecules, ultimately improving patient outcomes in cancer treatment.